TY - JOUR
T1 - Rationale and Design of the Canadian Outcomes Registry Late After Tetralogy of Fallot Repair
T2 - The CORRELATE Study
AU - Wald, Rachel M.
AU - Altaha, Mustafa A.
AU - Alvarez, Nanette
AU - Caldarone, Christopher A.
AU - Cavallé-Garrido, Tiscar
AU - Dallaire, Frédéric
AU - Drolet, Christian
AU - Grewal, Jasmine
AU - Hancock Friesen, Camille L.
AU - Human, Derek G.
AU - Hickey, Edward
AU - Kayedpour, Camilla
AU - Khairy, Paul
AU - Kovacs, Adrienne H.
AU - Lebovic, Gerald
AU - McCrindle, Brian W.
AU - Nadeem, Syed Najaf
AU - Patton, David J.
AU - Redington, Andrew N.
AU - Silversides, Candice K.
AU - Tham, Edythe B.
AU - Therrien, Judith
AU - Warren, Andrew E.
AU - Wintersperger, Bernd J.
AU - Vonder Muhll, Isabelle F.
AU - Farkouh, Michael E.
N1 - Funding Information:
The CORRELATE study is funded by the Canadian Institutes of Health Research ( MOP 119353 ).
Publisher Copyright:
© 2014 Canadian Cardiovascular Society.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Background: Chronic hemodynamically relevant pulmonary regurgitation (PR) resulting in important right ventricular dilation and ventricular dysfunction is commonly seen after tetralogy of Fallot (TOF) repair. Late adverse clinical outcomes, including exercise intolerance, arrhythmias, heart failure and/or death accelerate in the third decade of life and are cause for considerable concern. Timing of pulmonary valve replacement (PVR) to address chronic PR is controversial, particularly in asymptomatic individuals, and effect of PVR on clinical measures has not been determined. Methods: Canadian Outcomes Registry Late After Tetralogy of Fallot Repair (CORRELATE) is a prospective, multicentre, Canada-wide cohort study. Candidates will be included if they are ≥ 12 years of age, have had surgically repaired TOF resulting in moderate or severe PR, and are able to undergo cardiovascular magnetic resonance imaging. Enrollment of > 1000 individuals from 15 participating centres (Toronto, Montreal, Quebec City, Sherbrooke, Halifax, Calgary, Edmonton, and Vancouver) is anticipated. Clinical data, health-related quality of life metrics, and adverse outcomes will be entered into a web-based database. A central core lab will analyze all cardiovascular magnetic resonance studies (PR severity, right ventricular volumes, and ventricular function). Major adverse outcomes (sustained ventricular tachycardia and cardiovascular cause of death) will be centrally adjudicated. Results: To the best of our knowledge, CORRELATE will be the first prospective pan-Canadian cohort study of congenital heart disease in children and adults. Conclusions: CORRELATE will uniquely link clinical, imaging, and functional data in those with repaired TOF and important PR, thereby enabling critical evaluation of clinically relevant outcomes in those managed conservatively compared with those referred for PVR.
AB - Background: Chronic hemodynamically relevant pulmonary regurgitation (PR) resulting in important right ventricular dilation and ventricular dysfunction is commonly seen after tetralogy of Fallot (TOF) repair. Late adverse clinical outcomes, including exercise intolerance, arrhythmias, heart failure and/or death accelerate in the third decade of life and are cause for considerable concern. Timing of pulmonary valve replacement (PVR) to address chronic PR is controversial, particularly in asymptomatic individuals, and effect of PVR on clinical measures has not been determined. Methods: Canadian Outcomes Registry Late After Tetralogy of Fallot Repair (CORRELATE) is a prospective, multicentre, Canada-wide cohort study. Candidates will be included if they are ≥ 12 years of age, have had surgically repaired TOF resulting in moderate or severe PR, and are able to undergo cardiovascular magnetic resonance imaging. Enrollment of > 1000 individuals from 15 participating centres (Toronto, Montreal, Quebec City, Sherbrooke, Halifax, Calgary, Edmonton, and Vancouver) is anticipated. Clinical data, health-related quality of life metrics, and adverse outcomes will be entered into a web-based database. A central core lab will analyze all cardiovascular magnetic resonance studies (PR severity, right ventricular volumes, and ventricular function). Major adverse outcomes (sustained ventricular tachycardia and cardiovascular cause of death) will be centrally adjudicated. Results: To the best of our knowledge, CORRELATE will be the first prospective pan-Canadian cohort study of congenital heart disease in children and adults. Conclusions: CORRELATE will uniquely link clinical, imaging, and functional data in those with repaired TOF and important PR, thereby enabling critical evaluation of clinically relevant outcomes in those managed conservatively compared with those referred for PVR.
UR - http://www.scopus.com/inward/record.url?scp=84908469658&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908469658&partnerID=8YFLogxK
U2 - 10.1016/j.cjca.2014.06.011
DO - 10.1016/j.cjca.2014.06.011
M3 - Article
C2 - 25239650
AN - SCOPUS:84908469658
SN - 0828-282X
VL - 30
SP - 1436
EP - 1443
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
IS - 11
ER -